(Q24201328)

30 June 2019

meta-analysis

0 references

title

Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea (English)

1 reference

30 June 2019

enterotoxigenic Escherichia coli

main subject

Escherichia coli

0 references

diarrhea

0 references

1 reference

5

Firdausi Qadri

Firdausi

Qadri

1 reference

19 October 2023

4

David Sinclair

David

Sinclair

2 references

30 June 2019

19 October 2023

Tanvir Ahmed

1

Tanvir

Ahmed

2 references

30 June 2019

19 October 2023

Taufiqur R Bhuiyan

series ordinal

2

author given names

Taufiqur R

author last names

Bhuiyan

2 references

30 June 2019

19 October 2023

K Zaman

series ordinal

3

author given names

K

author last names

Zaman

2 references

30 June 2019

19 October 2023

publication date

5 July 2013

1 reference

30 June 2019

Cochrane Database of Systematic Reviews

published in

1 reference

30 June 2019

issue

7

1 reference

30 June 2019

page(s)

CD009029

1 reference

30 June 2019

Exclusion of clinically atypical or microbiologically mixed diarrhoeal episodes from outcome events in a field trial of oral cholera vaccines

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18–36 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

An oral B subunit: whole cell vaccine against cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Immunisation of volunteers with a synthetic peptide vaccine for enterotoxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Homologous and cross-reactive immune responses to enterotoxigenic Escherichia coli colonization factors in Bangladeshi children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Immunologic response to oral cholera vaccination in a crossover study: a novel placebo effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Systematic review: prevention of travellers' diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Vaccines against mucosal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Vaccines against enterotoxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Travellers' diarrhoea - pros and cons of different prophylactic measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009029.PUB2

Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal

21 January 2018

1 reference

12 December 2020

Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees

1 reference

12 December 2020

Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report).

1 reference

12 December 2020

Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine

1 reference

12 December 2020

Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world

1 reference

12 December 2020

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

1 reference

12 December 2020

Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups

1 reference

12 December 2020

Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004.

1 reference

12 December 2020

Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh.

1 reference

12 December 2020

A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phas

1 reference

12 December 2020

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial

1 reference

12 December 2020

Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2.

1 reference

12 December 2020

Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to hetero

1 reference

12 December 2020

Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man.

1 reference

12 December 2020

Nutritional status, body size and severity of diarrhoea associated with rotavirus or enterotoxigenic Escherichia coli.

1 reference

12 December 2020

Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli

1 reference

12 December 2020

Adenosine diphosphate-ribosylation of adenylate cyclase catalyzed by heat-labile enterotoxin of Escherichia coli: comparison with cholera toxin

1 reference

12 December 2020

Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli

1 reference

12 December 2020

Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli

1 reference

12 December 2020

Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood

1 reference

12 December 2020

Safety, Immunogenicity, and Protective Efficacy of the Whole-Cell/Recombinant B Subunit (WC/rBS) Oral Cholera Vaccine Against Travelers' Diarrhea

1 reference

12 December 2020

10.1002/14651858.CD009029.PUB2

Identifiers

DOI

1 reference

30 June 2019

release_fbl2yhczxzckjbbwwmjl5trf2m

Fatcat ID

0 references

PMC publication ID

6532719

1 reference

30 June 2019

1 reference

30 June 2019